Water-soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7-nAChR dysfunction

J Neurochem. 2020 Oct;155(1):45-61. doi: 10.1111/jnc.15018. Epub 2020 May 10.

Abstract

Lynx1 is a GPI-tethered protein colocalized with nicotinic acetylcholine receptors (nAChRs) in the brain areas important for learning and memory. Previously, we demonstrated that at low micromolar concentrations the water-soluble Lynx1 variant lacking GPI-anchor (ws-Lynx1) acts on α7-nAChRs as a positive allosteric modulator. We hypothesized that ws-Lynx1 could be used for improvement of cognitive processes dependent on nAChRs. Here we showed that 2 µM ws-Lynx1 increased the acetylcholine-evoked current at α7-nAChRs in the rat primary visual cortex L1 interneurons. At higher concentrations ws-Lynx1 inhibits α7-nAChRs expressed in Xenopus laevis oocytes with IC50 ~ 50 µM. In mice, ws-Lynx1 penetrated the blood-brain barrier upon intranasal administration and accumulated in the cortex, hippocampus, and cerebellum. Chronic ws-Lynx1 treatment prevented the olfactory memory and motor learning impairment induced by the α7-nAChRs inhibitor methyllycaconitine (MLA). Enhanced long-term potentiation and increased paired-pulse facilitation ratio were observed in the hippocampal slices incubated with ws-Lynx1 and in the slices from ws-Lynx1-treated mice. Long-term potentiation blockade observed in MLA-treated mice was abolished by ws-Lynx1 co-administration. To understand the mechanism of ws-Lynx1 action, we studied the interaction of ws-Lynx1 and MLA at α7-nAChRs, measured the basal concentrations of endogenous Lynx1 and the α7 nAChR subunit and their association in the mouse brain. Our findings suggest that endogenous Lynx1 limits α7-nAChRs activation in the adult brain. Ws-Lynx1 partially displaces Lynx1 causing positive modulation of α7-nAChRs and enhancement of synaptic plasticity. Ws-Lynx1 and similar compounds may constitute useful hits for treatment of cognitive deficits associated with the cholinergic system dysfunction.

Keywords: Ly6/uPAR; cognitive function; long-term potentiation; neurodegeneration; nicotinic acetylcholine receptor; positive allosteric modulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Adaptor Proteins, Signal Transducing / pharmacokinetics
  • Adaptor Proteins, Signal Transducing / pharmacology*
  • Alkaloids / pharmacology
  • Animals
  • Blood-Brain Barrier / drug effects
  • Brain / metabolism
  • Cholinesterase Inhibitors / toxicity*
  • Cognitive Dysfunction / chemically induced
  • Cognitive Dysfunction / prevention & control*
  • Cognitive Dysfunction / psychology*
  • Interneurons / drug effects
  • Learning / drug effects
  • Long-Term Potentiation / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuronal Plasticity / drug effects*
  • Rats
  • Rats, Wistar
  • Smell / drug effects
  • Visual Cortex / drug effects
  • Xenopus laevis
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors*

Substances

  • Adaptor Proteins, Signal Transducing
  • Alkaloids
  • Cholinesterase Inhibitors
  • LYNX1 protein, human
  • alpha7 Nicotinic Acetylcholine Receptor
  • lycaconitine
  • Acetylcholine